Despite this, YAP1 failed to confirm a unique subtype in a subsequent validation study,12 and a novel, inflamed subtype (designated as SCLC‐I) was then proposed for those unclassified tumors.13 This evidence concerns the gene YAP1 and small cell lung carcinoma.